Última Hora: "Facebook sobre a Cambridge Analytica: ?Não lemos todos os termos e condições" - Jornal de Negócios - Portugal" Thu, 26 Apr 2018 12:35:55 GMT    "Aquisições este ano? "Gostamos de surpreender", diz Corticeira Amorim - Jornal de Negócios - Portugal" Thu, 26 Apr 2018 21:50:00 GMT    "Vai passar a ser mais fácil comparar comissões bancárias - Dinheiro Vivo" Thu, 26 Apr 2018 16:11:00 GMT    "Turistas chegam a passar duas horas nas filas do aeroporto de Lisboa - TVI24" Thu, 26 Apr 2018 10:34:00 GMT   "" Thu, 26 Apr 2018 23:46:39 GMT    "Bruxelas lança confusão sobre TGV. Linha afinal é só para mercadorias - Diário de Notícias - Lisboa" Thu, 26 Apr 2018 23:23:00 GMT    "Nova Geração de Políticas de Habitação evitará despejos de inquilinos - Jornal de Notícias" Thu, 26 Apr 2018 18:14:43 GMT    "Centeno: Agências de rating mostram reconhecimento abrangente dos progressos de Portugal - Jornal de Negócios - Portugal" Thu, 26 Apr 2018 19:21:26 GMT    "Ministro da Saúde desbloqueia impasse na deslocalização do Infarmed para o Porto - Expresso" Thu, 26 Apr 2018 19:48:00 GMT    "O que mudou com Centeno no Eurogrupo? ?Nada?, acusa Varoufakis - Observador" Thu, 26 Apr 2018 07:53:33 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Activo não encontrado Sepracor Inc. - [Ticker: SEPR]Gráfico Sepracor Inc.  Notícias Sepracor Inc.  Download de Históricos Metastock Sepracor Inc. e Outros  Análise Técnica Sepracor Inc.  
Última TradeRange 52 Semanas[0,000 - 0,000]
Hora da Última TradeN/A - N/APrice-Target 1 AnoN/A
Variação ()Capitalização Bolsista3
Bid / AskN/AEPS0,00
AberturaPER12,69%
MáximoPagamento DividendoN/A
MínimoData Ex-DividendoN/A
Fecho Anterior0,000YieldN/A
VolumeVolume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.
Ver cotações de outros activos

Intraday   5 dias   1 mes   3 meses   6 meses   1 ano   2 anos   5 anos   10 anos            Use este gráfico no seu website!
Gráfico de Sepracor Inc. -  [Ticker: SEPR]
Mudar para Gráfico de Análise Técnica Interactiva de Sepracor Inc.

Últimos 10 Tópicos no Fórum sobre Sepracor Inc.:
Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc..

 Notícias sobre Sepracor Inc. [SEPR]:   (ordenadas por relevância)

Drugmakers Duped Medicaid Rebate Regulators, 3rd Circ. Told
Law360
Streck served as a relator under the qui tam provision of the FCA on behalf of the federal government, 23 states and Washington, D.C., court records show. In addition to Allergan, AstraZeneca and NovoNordisk, the defendants included Amgen Inc., Biogen ...

e mais »

Business Wire (press release)

Kala Pharmaceuticals Appoints Eric Trachtenberg as General Counsel and Corporate Secretary
Business Wire (press release)
Previously, Mr. Trachtenberg served in similar capacities for Pozen Inc., Aralez's predecessor, which he joined in June 2015. Mr. Trachtenberg formerly served as Deputy General Counsel at Auxilium Pharmaceuticals, Inc., from 2012 through its ...

e mais »

United States Asthma Medication Market Report 2018-2025
The Mobile Herald
United States Asthma Medication market competition by top manufacturers/players, with Asthma Medication sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Dulera, QVAR, Glaxosmithkline ...


Form DEF 14A Pulmatrix, Inc. For: Jun 05
StreetInsider.com
Prior to joining Sepracor Inc., Mr. Iwicki was at Novartis Pharmaceuticals Corporation from March 1998 to October 2007, where he was vice president and business unit head. Before that, he held management positions at Astra Merck Inc. and Merck & Co ...


Form PRE 14A GI DYNAMICS, INC. For: May 21
StreetInsider.com
GI DYNAMICS, INC. PO Box 51915. Boston, MA 02205. May 1, 2018. Dear Stockholder: You are cordially invited to attend the 2018 annual meeting of stockholders of GI Dynamics, Inc. (the ?Annual Meeting?), to be held on May 21, 2018, at 6:00 p.m., United ...

e mais »

Allergy Treatment Market - Evolving Industry Trends and Key Insights by 2024
Digital Journal
Zion Market Research, the market research group announced the analysis report titled "Allergy Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016?2024 ". This press release was orginally distributed by SBWire ...

e mais »

United States Asthma Medication Market Analysis Report 2018-2025
Facts of Week
United States Asthma Medication market competition by top manufacturers/players, with Asthma Medication sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Dulera, QVAR, Glaxosmithkline ...

e mais »

LANews By Abhishek Budholiya (press release) (blog)

Upcoming Market Forecast Study to Assess the Expansion of Allergy Treatment Market for 2016-2026 Period
LANews By Abhishek Budholiya (press release) (blog)
Some of the key market players in global allergy treatment market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical ...

e mais »

Allergy Treatment Market Forecast By End-use Industry 2016-2026
Facts of Week
Some of the key market players in global allergy treatment market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical ...

e mais »

BSA bureau (press release)

Sumitomo Dainippon appoints Nomura as President & CEO
BSA bureau (press release)
In 2005, he took charge as the Senior Director, Finance & Accounting in Sumitomo Dainippon Pharma. Since then, Nomura has been leading different roles and responsibilities in the company. In 2010, Sunovion (formerly Sepracor Inc.), was acquired by ...

e mais »

Business Wire (press release)

BioClin Therapeutics Appoints Graeme Currie, Ph.D., as Chief Operating Officer and Esteban (Steve) Abella, MD, as ...
Business Wire (press release)
Dr. Currie has over 25 years of drug development experience in both pharmaceutical and biotechnology companies, having held senior leadership roles at Dynavax Technologies Corp., Regeneron Pharmaceuticals, Sepracor Inc. and PDL Biopharma. Dr. Abella ...

e mais »

Bellicum Pharmaceuticals Appoints Edmund P. Harrigan, MD to its Board of Directors
GlobeNewswire (press release)
In addition to his experience at Pfizer, Dr. Harrigan previously served as President & CEO of Karuna Pharmaceuticals, and in senior clinical leadership positions at Neurogen Corp. and Sepracor, Inc. Prior to entering the pharmaceutical industry in 1990 ...

e mais »

Kala Pharmaceuticals Appoints Todd Bazemore as Chief Operating Officer
Business Wire (press release)
Prior to joining Dyax, Todd was at Sunovion Pharmaceuticals, Inc. (previously Sepracor Inc., prior to its acquisition by Sumitomo Dainippon Pharma Co., Ltd), where he served in several roles of increasing responsibility including Vice President ...

e mais »

Spero Announces Appointment of David P. Southwell to its Board of Directors
GlobeNewswire (press release)
CAMBRIDGE, Mass., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant bacterial ...

e mais »

Asthma Medication Market Overview, Top Manufactures, Market Size, Industry Growth Analysis & Forecast: 2022
Pharmaceuticals News
Asthma Medication Market is a comprehensive analysis of report provides detailed overview of major challenges, opportunities, current market trends and strategies impacting the global market along with estimates and forecast of revenue and share ...

Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc.

Largura do Site:

 Imagem de Fundo:

Copyright@1998-2018 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters